Literature DB >> 23643784

Controlling the physical form of mannitol in freeze-dried systems.

Mehak Mehta1, Sunny P Bhardwaj, Raj Suryanarayanan.   

Abstract

A potential drawback with the use of mannitol as a bulking agent is its existence as mannitol hemihydrate (MHH; C₆H₁₄O₆·0.5H₂O) in the lyophile. Once formed during freeze-drying, MHH dehydration may require secondary drying under aggressive conditions which can be detrimental to the stability of thermolabile components. If MHH is retained in the lyophile, the water released by MHH dehydration during storage has the potential to cause product instability. We systematically identified the conditions under which anhydrous mannitol and MHH crystallized in frozen systems with the goal of preventing MHH formation during freeze-drying. When mannitol solutions were cooled, the temperature of solute crystallization was the determinant of the physical form of mannitol. Based on low temperature X-ray diffractometry (using both laboratory and synchrotron sources), MHH formation was observed when solute crystallization occurred at temperatures ≤ -20 °C, while anhydrous mannitol crystallized at temperatures ≤ -10 °C. The transition temperature (anhydrate - MHH) appears to be ∼-15 °C. The use of a freeze-dryer with controlled ice nucleation technology enabled anhydrous mannitol crystallization at ∼-5 °C. Thus, ice crystallization followed by annealing at temperatures ≤ -10 °C can be an effective strategy to prevent MHH formation.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Annealing; Controlled ice nucleation; Freeze-drying; MHH; Mannitol; Mannitol hemihydrate; Synchrotron XRD; X-ray diffractometry; XRD

Mesh:

Substances:

Year:  2013        PMID: 23643784     DOI: 10.1016/j.ejpb.2013.04.010

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  6 in total

Review 1.  The Principles of Freeze-Drying and Application of Analytical Technologies.

Authors:  Kevin R Ward; Paul Matejtschuk
Journal:  Methods Mol Biol       Date:  2021

2.  Nanobubbles in Reconstituted Lyophilized Formulations: Interaction With Proteins and Mechanism of Formation.

Authors:  Jared R Snell; N S Krishna Kumar; Raj Suryanarayanan; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2019-05-13       Impact factor: 3.534

3.  Intra-Vial Heterogeneity in Physical Form of Mannitol in Colyophilized Binary Systems.

Authors:  S Thakral; S Koranne; R Suryanarayanan
Journal:  Pharm Res       Date:  2018-09-21       Impact factor: 4.200

4.  Development of thermostable lyophilized inactivated polio vaccine.

Authors:  Heleen Kraan; Paul van Herpen; Gideon Kersten; Jean-Pierre Amorij
Journal:  Pharm Res       Date:  2014-04-24       Impact factor: 4.200

5.  Optimization of Curcumin Nanocrystals as Promising Strategy for Nose-to-Brain Delivery Application.

Authors:  Angela Bonaccorso; Maria Rosa Gigliobianco; Rosalia Pellitteri; Debora Santonocito; Claudia Carbone; Piera Di Martino; Giovanni Puglisi; Teresa Musumeci
Journal:  Pharmaceutics       Date:  2020-05-23       Impact factor: 6.321

6.  The Promising Role of Chitosan-Poloxamer 188 Nanocrystals in Improving Diosmin Dissolution and Therapeutic Efficacy against Ferrous Sulfate-Induced Hepatic Injury in Rats.

Authors:  Neamet S Lotfy; Thanaa M Borg; Elham A Mohamed
Journal:  Pharmaceutics       Date:  2021-12-05       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.